Guidance on CMC elements for somatic cell therapy products
This article was originally published in The Gold Sheet
Executive Summary
FDA issued a guidance on CMC information for human somatic cell therapy INDs on April 10. It replaces an August 2003 draft. The review instructions and template described in the guidance are designed to help FDA reviewers in evaluating INDs for these products. The guidance contains detailed requirements for characterizing master cell banks, working cell banks and reagents. It also states that manufacturers should include a detailed description of all procedures use during the collection, production and purification of cellular therapy products
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.